We are excited to share that Dr. Andrew Coveler has been appointed Interim Director of Clinical Trials at the Cancer Vaccine Institute. In his new role at the CVI, he will help develop new strategies to support the growth of our clinical trials program bringing novel vaccines and other immune therapies to patients. Dr. Coveler will work with faculty and clinical staff on streamlining operations and expanding our reach across all CVI disease programs.
Dr. Coveler received his medical degree from Northwestern University in 2002, completed his internship at Baylor College of Medicine in 2003, and his internal medicine residency at the University of Washington in 2005. He joined the CVI in 2005 as a Senior Research Fellow, seeing patients on trials and developing trials and processes. He then went on to his formal oncology training at the Fred Hutch, completing fellowship in 2010. Since then he has been promoted to Associate Professor at the University of Washington and Fred Hutchinson Cancer Research Center. Dr. Coveler is also the director of the pancreas cancer clinic at the Seattle Cancer Care Alliance (SCCA), a member of the GI Oncology and Phase 1 teams at SCCA, and is thrilled to enter this new role at CVI to take our clinical research program to new heights.
As a bonus, Dr. Coveler was also selected by his peers as one of Seattle Met’s Top Doctors in the Hematology / Oncology category. In his free time, Dr. Coveler enjoys spending time with his family and wishes he had learned to bake during the pandemic.